Suchergebnisse - "Cohen, Mark S"

PubPharm (12)

1

Advances in the discovery and development of melanoma drug therapies

enthalten in: Expert opinion on drug discovery | 2021

von Chanda, M. | Cohen, M.

2

A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas

enthalten in: Melanoma research | 2021

von Sanchez, J. | Subramanian, C. | Chanda, M. | +6

3

The discovery and development of binimetinib for the treatment of melanoma

enthalten in: Expert opinion on drug discovery | 2020

von Tran, B. | Cohen, M.

4

Over expression of DNA damage and cell cycle dependent proteins are associated with poor survival in patients with adrenocortical carcinoma

enthalten in: Surgery | 2019

von Subramanian, C. | Cohen, M.

CommentIn: Surgery. 2019 Jan;165(1):210. - PMID 30527005

5

BRAF and MEK Inhibitors : Use and Resistance in BRAF-Mutated Cancers

enthalten in: Drugs | 2018

von Sanchez, J. | Wang, T. | Cohen, M.

6

The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma

enthalten in: Expert opinion on drug discovery | 2016

von Kim, A. | Cohen, M.

7

Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation

enthalten in: Investigational new drugs | 2014

von Grogan, P. | Sarkaria, J. | Timmermann, B. | +1

8

Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways

enthalten in: Investigational new drugs | 2013

von Grogan, P. | Sleder, K. | Samadi, A. | +3

9

Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway

enthalten in: Surgery | 2012

von Samadi, A. | Bazzill, J. | Zhang, X. | +6

10

Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2012

von Samadi, A. | Cohen, S. | Mukerji, R. | +5